1. Home
  2. GSIW vs CMND Comparison

GSIW vs CMND Comparison

Compare GSIW & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSIW

Garden Stage Limited

HOLD

Current Price

$0.13

Market Cap

28.6M

Sector

N/A

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$2.29

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIW
CMND
Founded
2016
2017
Country
Hong Kong
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
5.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GSIW
CMND
Price
$0.13
$2.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
299.7K
448.1K
Earning Date
01-01-0001
01-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,368,221.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
283.23
N/A
52 Week Low
$0.09
$2.23
52 Week High
$1.79
$87.20

Technical Indicators

Market Signals
Indicator
GSIW
CMND
Relative Strength Index (RSI) 39.19 70.80
Support Level $0.13 $2.40
Resistance Level $0.14 $2.88
Average True Range (ATR) 0.01 0.20
MACD -0.00 0.19
Stochastic Oscillator 12.65 69.85

Price Performance

Historical Comparison
GSIW
CMND

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: